ArticleBMJ global health2026
Bringing severe non-communicable disease care to district-level hospitals in Nepal: PEN-Plus experience and regional policy implications.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Scoring System for the Assessment of Quality of Care in the Management of Transfusion Dependent Thalassemia.Hematology reports · 2026Review
- Visual Identity, Social Branding, and Advocacy: Development of the PEN-Plus Logo for Severe Non-Communicable Disease Care in Nepal.Public health challenges · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe non-communicable diseases (NCDs) such as type 1 diabetes mellitus (T1DM), sickle cell disease (SCD), thalassaemia and congenital heart conditions are prevalent in low-resource settings but remain largely unaddressed in the primary care system. Nepal's Package of Essential NCD Interventions-Plus (PEN-Plus) initiative demonstrates how peripheral provincial hospitals (former district hospitals) can effectively deliver decentralised, equitable care for childhood-originated NCDs such as T1DM, SCD, thalassaemia, rheumatic and congenital heart diseases, epilepsy and childhood asthma. Led by the Ministry of Health and Population, Epidemiology and Disease Control Division in partnership with key stakeholders, the programme has been implemented in six districts of Nepal, offering early diagnosis, treatment, social protection and follow-up care. Early implementation demonstrates feasibility, with 3278 patients receiving care through PEN-Plus clinics over 2 years using modest investments and existing district hospital resources. Scalability is supported by the expansion from two to six districts and by government policy commitments, including provincial budget allocations for further rollout. This paper presents an overview of the PEN-Plus programme in Nepal, its design, implementation and early outcomes, illustrating how this approach offers a scalable solution for severe NCD care in resource-constrained settings. The PEN-Plus model provides critical policy insights and valuable lessons for other South Asian countries and low- and middle-income countries seeking to strengthen equitable NCD care through decentralised health systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.